We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Pilot to Test Benefits of Early Talks Between Drugmakers, HTAs
EC Pilot to Test Benefits of Early Talks Between Drugmakers, HTAs
The European Commission is looking for drugmakers to participate in pilots on early dialogue with health technology assessors, with the aim of better aligning new product development and HTA requirements.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor